💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

UK offers $30 million contract to maintain drug supply after Brexit

Published 08/14/2019, 07:16 PM
Updated 08/14/2019, 07:21 PM
UK offers $30 million contract to maintain drug supply after Brexit

LONDON (Reuters) - Britain is asking logistics providers to bid for a 25 million pound ($30 million) express freight contract to deliver medicines into the country on a daily basis after it has left the European Union on Oct. 31.

The Department for Health and Social Care said the contract would form part of its contingency plans to deal with any complications that stem from Britain's departure from the world's biggest trading bloc.

The service is intended to deliver small parcels of medicines or medical products on a 24-hour basis, with an additional provision to move larger pallets carrying goods on a two-to-four day basis.

"I want to ensure that when we leave the EU at the end of October, all appropriate steps have been taken to ensure frontline services are fully prepared," health minister Chris Skidmore said in a statement.

The contract will run for 12 months, with a possible further 12-month extension. The department has already sought to help companies build up buffer stocks of medicines and procured additional warehouse space.

The British government was embarrassed earlier this year after it signed a 14 million pound contract with a company to provide extra ferries in the event of a no-deal Brexit, even though the company did not have any ships. It later scrapped that contract.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.